Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral- Therapy-Naive Patients Infected with HIV-1-Reference-Cited by-同舟云学术

Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral- Therapy-Naive Patients Infected with HIV-1

Published:2004-10-19 Issue:1 Volume:1 Page:e19
ISSN:1549-1676
Container-title:PLoS Medicine
language:en
Short-container-title:PLoS Med

Author:

van Leth Frank,Phanuphak Prahpan,Stroes Erik,Gazzard Brian,Cahn Pedro,Raffi François,Wood Robin,Bloch Mark,Katlama Christine,Kastelein John J. P,Schechter Mauro,Murphy Robert L,Horban Andrzej,Hall David B,Lange Joep M. A,Reiss Peter

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference57 articles.

1. Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study

2. Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

3. Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes

4. Restoration of Endothelial Function by Increasing High-Density Lipoprotein in Subjects With Isolated Low High-Density Lipoprotein

5. High-Density Lipoproteins: A New Potential Therapeutic Target for the Prevention of Cardiovascular Disease

Cited by 221 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mass Spectrometry Imaging Reveals Region-Specific Lipid Alterations in the Mouse Brain in Response to Efavirenz Treatment;ACS Pharmacology & Translational Science;2024-07-09

2. Dyslipidemia among adult HIV patients on antiretroviral therapy and its association with age and body mass index in Ethiopia: A systematic review and meta-analysis;PLOS ONE;2024-05-09

3. Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies;Viruses;2024-04-10

4. Efficacy and effect on lipid profiles of switching to ainuovirine-based regimen versus continuing efavirenz-based regimen in people with HIV-1: 24-week results from a real-world, retrospective, multi-center cohort study;Antimicrobial Agents and Chemotherapy;2024-04-03

5. Pathophysiology and Clinical Management of Dyslipidemia in People Living with HIV: Sailing through Rough Seas;Life;2024-03-28